How do I buy Johnson & Johnson (JNJ) stock?

Buying Johnson & Johnson (JNJ) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "JNJ", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy JNJ by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

What is the minimum investment for JNJ on Gotrade?

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Johnson & Johnson from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Does Johnson & Johnson (JNJ) pay dividends?

Yes, Johnson & Johnson regularly pays dividends to shareholders. Currently, the estimated dividend yield for JNJ is around 2.02% per year. On Gotrade, cash dividends will be automatically credited to your account balance (after taxes).

Is buying JNJ on Gotrade safe and legal?

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

What are the market hours to buy JNJ?

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours. Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

How do I tell if JNJ is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Johnson & Johnson (JNJ) Stock Price: Oct 9 Close $261.44

Latest news

Stocktwits

Stocktwits Pharma Pulse: JNJ Earnings, Cancer Updates And Two FDA Target Dates — The Week’s Biotech Watchlist

JNJOctober 12, 2026

Stocktwits

Stocktwits Pharma Pulse: JNJ Earnings, Cancer Updates And Two FDA Target Dates — The Week’s Biotech Watchlist

JNJ

Stocktwits

SLS Stock Jumps Overnight: Retail Sees Big Pharma Buyout Clues In 'M&A Negotiation Lounge' Booth At ASH

JNJOctober 12, 2026

Stocktwits

SLS Stock Jumps Overnight: Retail Sees Big Pharma Buyout Clues In 'M&A Negotiation Lounge' Booth At ASH

JNJ

Stocktwits

What To Expect In Markets This Week: JPM, GS, C Bank Earnings, CPI Report, Kevin Warsh's Speech And More

JNJOctober 11, 2026

Stocktwits

What To Expect In Markets This Week: JPM, GS, C Bank Earnings, CPI Report, Kevin Warsh's Speech And More

JNJ

Zacks Investment Research

Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Share Its Reliability

PositiveJNJOctober 6, 2026

24/7 Wall StreetPositive

Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Share Its Reliability

JNJ

Zacks Investment Research

Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?

NeutralJNJOctober 6, 2026

Zacks Investment ResearchNeutral

Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?

JNJ

24/7 Wall Street

Johnson & Johnson or Procter & Gamble: If I Could Only Own 1 Dividend King for 20 Years, This Is It

PositiveJNJOctober 6, 2026

24/7 Wall StreetPositive

Johnson & Johnson or Procter & Gamble: If I Could Only Own 1 Dividend King for 20 Years, This Is It

JNJ

Zacks Investment Research

Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note

NeutralJNJOctober 5, 2026

Zacks Investment ResearchNeutral

Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note

JNJ

Zacks Investment Research

Pfizer vs. J&J: Comparing Growth, Patent Risks and Valuation

NeutralJNJOctober 5, 2026

Zacks Investment ResearchNeutral

Pfizer vs. J&J: Comparing Growth, Patent Risks and Valuation

JNJ

News tone: automated (AI) classification of the article's content, not a price prediction.

About Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. Every day, our more than 130,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.

SectorHealthcare

IndustryDrug Manufacturers - General

Employees138,200

CEOMr. Joaquin Duato

IPO DateSep 24, 1944

HeadquartersNew Brunswick, NJ

Key Executives

Name	Title	Year Born
Mr. Joaquin Duato	CEO & Chairman	1963
Mr. Joseph James Wolk CPA	Executive VP & CFO	1967
Dr. John C. Reed M.D., Ph.D.	Executive Vice President of Innovative Medicine and R&D	1958
Mr. Timothy Schmid	Executive VP & Worldwide Chairman of MedTech	1970
Mr. Robert J. Decker Jr.	Controller & Chief Accounting Officer	1973
Mr. James Swanson	Executive VP & Chief Information Officer	1966
Mr. Ryan Koors	Vice President of Investor Relations	—
Mr. Dirk Brinckman	Chief Compliance Officer	—
Ms. Elizabeth Forminard J.D.	Executive VP & Chief Legal Officer	1971
Ms. Kristen Blair Mulholland	Executive VP & Chief Human Resources Officer	1967

Fundamentals

Valuation

Market cap$630.04B

Price-to-sales ratio6.31

Price-to-book value7.27

Price-earnings ratio29.40

Return on Equity26.00%

Return on Sales27.00%

Return on Assets11.00%

PEG ratio2.82

Earnings Per Share

Earnings Per Share$8.73

Income Statement

Average volume6,662,075

EBITDA$33.96B

1 year high (52w)$281.07

1 year low (52w)$184.66

Dividend

Ex dividend date25 Aug 2026

Dividend amount$1.34

Dividend yield2.02%

Last payment date8 Sep 2026

Next earnings report13 Oct 2026

Source: third-party data provider, as of October 12, 2026

Technical indicators

RSI 14: 46.71
MACD 12/26/9: -2.62
EMA 9 of MACD: -1.57
MACD histogram: -1.06
SMA 50: $265.33; Price below SMA 50
EMA 50: $262.70; Price below EMA 50
SMA 200: $242.92; Price above SMA 200
EMA 200: $241.56; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of October 9, 2026. Technical data, not a recommendation.

Analyst views

11 analyst ratings

Third-party analyst opinion, not a recommendation from Gotrade.

Analyst consensus:Buy

91% Buy

9% Hold

0% Sell

Analyst price target

Low: $265.00
Average: $293.91
High: $320.00

JP Morgan

Chris Schott

Hold

Target price

$285.00

Morgan Stanley

Terence Flynn

Buy

Target price

$294.00

Citigroup

Joanne Wuensch

Buy

Target price

$303.00

HSBC

Rajesh Kumar

Buy

Target price

$320.00

Guggenheim

Vamil Divan

Buy

Target price

$287.00

RBC Capital

Trung Huynh

Buy

Target price

$290.00

UBS

Michael Yee

Buy

Target price

$320.00

Raymond James

Jayson Bedford

Buy

Target price

$265.00

Wells Fargo

Larry Biegelsen

Buy

Target price

$282.00

RBC Capital

Shagun Singh

Buy

Target price

$287.00

TD Cowen

Michael Nedelcovych

Buy

Target price

$300.00

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021										+2.3	-4.3	+8.2
2022	+0.4	-3.7	+8.1	+1.3	+0.5	-0.1	-2.8	-7.2	-1.2	+6.6	+2.8	-1.2
2023	-8.3	-7.1	+1.6	+4.4	-5.2	+7.1	+2.6	-4.3	-2.9	-4.4	+4.0	-1.0
2024	-0.7	+1.9	-2.4	-8.4	-3.0	-1.1	+7.8	+3.2	-3.1	-1.3	-3.2	-6.6
2025	+5.6	+8.7	-0.9	+2.0	+0.5	-1.7	+5.7	+5.9	+4.1	+1.5	+11.1	+0.8
2026	+9.6	+7.7	-1.7	-5.8	-0.8	+13.6	+0.9	+4.5	-2.4	+1.1

Corporate actions

Upcoming

No upcoming corporate actions for JNJ

Past

DividendQ3/26

Ex-dividend date25 Aug 2026

Payable date8 Sep 2026

Amount per share$1.34

DividendQ2/26

Ex-dividend date26 May 2026

Payable date9 Jun 2026

Amount per share$1.34

DividendQ1/26

Ex-dividend date24 Feb 2026

Payable date10 Mar 2026

Amount per share$1.30

DividendQ4/25

Ex-dividend date25 Nov 2025

Payable date9 Dec 2025

Amount per share$1.30

DividendQ3/25

Ex-dividend date26 Aug 2025

Payable date9 Sep 2025

Amount per share$1.30

DividendQ2/25

Ex-dividend date27 May 2025

Payable date10 Jun 2025

Amount per share$1.30

DividendQ1/25

Ex-dividend date18 Feb 2025

Payable date4 Mar 2025

Amount per share$1.24

DividendQ4/24

Ex-dividend date26 Nov 2024

Payable date10 Dec 2024

Amount per share$1.24

DividendQ3/24

Ex-dividend date27 Aug 2024

Payable date10 Sep 2024

Amount per share$1.24

DividendQ2/24

Ex-dividend date20 May 2024

Payable date4 Jun 2024

Amount per share$1.24

DividendQ1/24

Ex-dividend date16 Feb 2024

Payable date5 Mar 2024

Amount per share$1.19

DividendQ4/23

Ex-dividend date20 Nov 2023

Payable date5 Dec 2023

Amount per share$1.19

DividendQ3/23

Ex-dividend date25 Aug 2023

Payable date7 Sep 2023

Amount per share$1.19

DividendQ2/23

Ex-dividend date22 May 2023

Payable date6 Jun 2023

Amount per share$1.19

DividendQ1/23

Ex-dividend date17 Feb 2023

Payable date7 Mar 2023

Amount per share$1.13

DividendQ4/22

Ex-dividend date21 Nov 2022

Payable date6 Dec 2022

Amount per share$1.13

DividendQ3/22

Ex-dividend date22 Aug 2022

Payable date6 Sep 2022

Amount per share$1.13

DividendQ2/22

Ex-dividend date23 May 2022

Payable date7 Jun 2022

Amount per share$1.13

DividendQ1/22

Ex-dividend date18 Feb 2022

Payable date8 Mar 2022

Amount per share$1.06

DividendQ4/21

Ex-dividend date22 Nov 2021

Payable date7 Dec 2021

Amount per share$1.06

Compare stocks

JNJ

Buy JNJ

Market cap

$630.04B

-

Price / Earnings ratio

29.40

-

Price / Sales ratio

6.31

-

Dividend yield

2.02%

-

Average volume

6,662,075

-

Earnings per share

$8.73

-

Johnson & Johnson (JNJ) Stock

Fundamentals

Compare with JNJ

Recent news

Stocktwits Pharma Pulse: JNJ Earnings, Cancer Updates And Two FDA Target Dates — The Week’s Biotech Watchlist

Stocktwits Pharma Pulse: JNJ Earnings, Cancer Updates And Two FDA Target Dates — The Week’s Biotech Watchlist

SLS Stock Jumps Overnight: Retail Sees Big Pharma Buyout Clues In 'M&A Negotiation Lounge' Booth At ASH

SLS Stock Jumps Overnight: Retail Sees Big Pharma Buyout Clues In 'M&A Negotiation Lounge' Booth At ASH

What To Expect In Markets This Week: JPM, GS, C Bank Earnings, CPI Report, Kevin Warsh's Speech And More

What To Expect In Markets This Week: JPM, GS, C Bank Earnings, CPI Report, Kevin Warsh's Speech And More

Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?

Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Stocktwits Pharma Pulse: JNJ Earnings, Cancer Updates And Two FDA Target Dates — The Week’s Biotech Watchlist

Stocktwits Pharma Pulse: JNJ Earnings, Cancer Updates And Two FDA Target Dates — The Week’s Biotech Watchlist

SLS Stock Jumps Overnight: Retail Sees Big Pharma Buyout Clues In 'M&A Negotiation Lounge' Booth At ASH

SLS Stock Jumps Overnight: Retail Sees Big Pharma Buyout Clues In 'M&A Negotiation Lounge' Booth At ASH

What To Expect In Markets This Week: JPM, GS, C Bank Earnings, CPI Report, Kevin Warsh's Speech And More

What To Expect In Markets This Week: JPM, GS, C Bank Earnings, CPI Report, Kevin Warsh's Speech And More

Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?

Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?

PFE vs. JNJ: Which Stock Is the Better Value Option?

PFE vs. JNJ: Which Stock Is the Better Value Option?

Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Share Its Reliability

Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Share Its Reliability

Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?

Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?

Johnson & Johnson or Procter & Gamble: If I Could Only Own 1 Dividend King for 20 Years, This Is It

Johnson & Johnson or Procter & Gamble: If I Could Only Own 1 Dividend King for 20 Years, This Is It

Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note

Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note

Pfizer vs. J&J: Comparing Growth, Patent Risks and Valuation

Pfizer vs. J&J: Comparing Growth, Patent Risks and Valuation

About Johnson & Johnson

Key Executives

Fundamentals

Valuation

Earnings Per Share

Income Statement

Dividend

Technical indicators

Analyst views

Seasonality

Corporate actions

Upcoming

Past

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade